Krediet E

ARQ National Psychotrauma Center, ARQ Centrum'45, The Netherlands.

9 papers

ArticleMDMA

The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis.

Bostoen TPL, Krediet E, van Schagen AM +2

Europe PMC2026
ArticlePsilocybin

Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study.

Koolen M, Wirsching A, Krediet E +1

Europe PMC2025
ArticleMDMA

A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy.

Passie T, Loizaga-Velder A, Danforth A +19

Europe PMC2026
ArticlePsilocybin

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

Breeksema JJ, Niemeijer A, Krediet E +5

Europe PMC2024
ArticleLSD

Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study.

Family N, Hendricks PS, Williams LT +4

Europe PMC2022
ArticlePsilocybin

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.

Breeksema JJ, Niemeijer AR, Krediet E +2

Europe PMC2020
ArticlePsilocybin

Reviewing the Potential of Psychedelics for the Treatment of PTSD.

Krediet E, Bostoen T, Breeksema J +3

Europe PMC2020
ArticlePsilocybin

[Psychedelics in the treatment of PTSD].

Vermetten E, Krediet E, Bostoen T +3

Europe PMC2020
ArticleLSD

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

Family N, Maillet EL, Williams LTJ +6

Europe PMC2020